STRO Historical Earnings image   This STRO historical earnings page last updated 5/21/2024
STRO Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20245/13/20240.01B
Q4 20233/25/20240.11B
Q3 202311/13/20230.02B
Q2 20238/10/20230.01B
Q1 20235/15/20230.01B
Q4 20223/30/20230.01B
Q3 202211/8/20220.03B
Q2 20228/8/20220.03B
Q1 20225/9/20220.01B
Q4 20212/28/20220.01B
Q3 202111/10/20210.01B
Q2 20218/9/20210.03B
Q1 20215/7/20210.01B
Q4 20203/18/20210.01B
Q3 202011/5/20200.02B
Q2 20208/6/20200.01B
Q1 20205/11/20200.01B
Q4 20193/16/20200.01B
Q3 201911/8/20190.01B
Q2 20198/14/20190.01B
Q1 20195/15/20190.01B
Q4 20184/1/201919.09M
Q3 201811/14/20187.84M
STRO Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q1 20245/13/2024-0.950
Q4 20233/25/20240.520
Q3 202311/13/2023-0.810
Q2 20238/10/2023-0.640
Q1 20235/15/2023-0.850
Q4 20223/30/2023-0.610
Q3 202211/8/2022-0.370
Q2 20228/8/2022-0.550
Q1 20225/9/2022-0.840
Q4 20212/28/2022-0.830
Q3 202111/10/2021-0.670
Q2 20218/9/2021-0.130
Q1 20215/7/2021-0.660
Q4 20203/18/2021-1.480
Q3 202011/5/20200.450
Q2 20208/6/2020-0.600
Q1 20205/11/2020-0.840
Q4 20193/16/2020-0.650
Q3 201911/8/2019-0.560
Q2 20198/14/2019-0.600
Q1 20195/15/2019-0.620
Q4 20184/1/2019-0.07
Q3 201811/14/2018-21.26
Quotes delayed 20 minutes

Email EnvelopeFree STRO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Sutro Biopharma (STRO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

STRR Historical Earnings
STSA Historical Earnings
STTK Historical Earnings
SUPN Historical Earnings
SURF Historical Earnings
SVRA Historical Earnings
SWAV Historical Earnings
SWTX Historical Earnings
SYBX Historical Earnings
SYK Historical Earnings
What was the record high STRO historical earnings result?
In terms of earnings or revenue, what is the best STRO historical earnings result that Sutro Biopharma has ever posted, and when?

✔️Accepted answer: Within our data set, the highest STRO historical earnings result was set in Q4 2023, when Sutro Biopharma posted results of 0.520/share. The most successful revenue quarter within our data set was Q4 2023 when Sutro Biopharma reported revenue of 0.11B.

What was the lowest Sutro Biopharma historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest STRO has reported, and when?

✔️Accepted answer: Within our data set, the lowest STRO historical earnings result was set in Q3 2018, when Sutro Biopharma posted results of -21.26/share. The smallest revenue quarter within our data set was Q1 2022 when Sutro Biopharma reported revenue of 0.01B.

On this page we presented the STRO historical earnings date information for Sutro Biopharma. Reviewing that STRO Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2023, when STRO posted gaap of 0.520/share. Meanwhile the lowest STRO historical earnings result was in Q3 2018, when STRO posted gaap of -21.26/share. Moving to Sutro Biopharmas historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2023 when STRO reported 0.11B in revenue, while the smallest revenue quarter was Q1 2022 when STRO reported 0.01B in revenue.

For self directed investors doing their due diligence on STRO or any other given stock, their research can benefit from looking into all of the Sutro Biopharma historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you to make it more convenient for investors to look into Sutro Biopharma historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for STRO. Thanks for visiting, and the next time you need to research STRO historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Top 10 Hedge Funds Holding United Rentals, Top Ten Hedge Funds Holding MHLD, Institutional Holders of ESPR.


STRO Historical Earnings | | Copyright © 2020 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.